The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancer. Read more about The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancer.
Genomic analysis of head and neck squamous cell carcinoma cell lines and human tumors: a rational approach to preclinical model selection. Read more about Genomic analysis of head and neck squamous cell carcinoma cell lines and human tumors: a rational approach to preclinical model selection.
Yes-associated protein 1 is activated and functions as an oncogene in meningiomas. Read more about Yes-associated protein 1 is activated and functions as an oncogene in meningiomas.
Pten regulates Aurora-A and cooperates with Fbxw7 in modulating radiation-induced tumor development. Read more about Pten regulates Aurora-A and cooperates with Fbxw7 in modulating radiation-induced tumor development.
Progressive genomic instability in the FVB/Kras(LA2) mouse model of lung cancer. Read more about Progressive genomic instability in the FVB/Kras(LA2) mouse model of lung cancer.
A coactivator role of CARM1 in the dysregulation of β-catenin activity in colorectal cancer cell growth and gene expression. Read more about A coactivator role of CARM1 in the dysregulation of β-catenin activity in colorectal cancer cell growth and gene expression.
Autophagy induction with RAD001 enhances chemosensitivity and radiosensitivity through Met inhibition in papillary thyroid cancer. Read more about Autophagy induction with RAD001 enhances chemosensitivity and radiosensitivity through Met inhibition in papillary thyroid cancer.
Bcl-2 overexpression induces a partial epithelial to mesenchymal transition and promotes squamous carcinoma cell invasion and metastasis. Read more about Bcl-2 overexpression induces a partial epithelial to mesenchymal transition and promotes squamous carcinoma cell invasion and metastasis.
Galectin-3 targeted therapy with a small molecule inhibitor activates apoptosis and enhances both chemosensitivity and radiosensitivity in papillary thyroid cancer. Read more about Galectin-3 targeted therapy with a small molecule inhibitor activates apoptosis and enhances both chemosensitivity and radiosensitivity in papillary thyroid cancer.
Loss-of-function fibroblast growth factor receptor-2 mutations in melanoma. Read more about Loss-of-function fibroblast growth factor receptor-2 mutations in melanoma.
